Atara Biotherapeutics resubmits tab-cel application to FDA

Go back to Atara Biotherapeutics resubmits tab-cel application to FDA
(NASDAQ: ATRA) Delayed: 8.38 +0.21 (2.57%)
Previous Close $8.17    52 Week High $40.80 
Open $8.17    52 Week Low $12.45 
Day High $8.67    P/E N/A 
Day Low $7.86    EPS $0.00 
Volume 34,492